June 25, 2017 7:37 PM ET


Company Overview of Dermira, Inc.

Company Overview

Dermira, Inc., a biopharmaceutical company, engages in identifying, developing, and commercializing therapies to enhance the lives of patients with dermatologic diseases primarily in the United States. The company’s late-stage product candidates include Cimzia, an injectable biologic tumor necrosis factor-alpha inhibitor to treat various inflammatory diseases, as well as to treat patients with moderate-to-severe chronic plaque psoriasis; Glycopyrronium tosylate, a small-molecule anticholinergic product that is in Phase III clinical trial for the treatment of primary axillary hyperhidrosis or excessive underarm sweating; and Olumacostat glasaretil, a small-molecule sebum inhibitor, which is i...

275 Middlefield Road

Suite 150

Menlo Park, CA 94025

United States

Founded in 2010

95 Employees



Key Executives for Dermira, Inc.

Co-Founder, Chairman and Chief Executive Officer
Age: 64
Total Annual Compensation: $500.0K
Co-Founder, Chief Medical Officer and Director
Age: 74
Total Annual Compensation: $360.8K
Co-Founder and Senior Vice President of Corporate Development & Strategy
Age: 40
Total Annual Compensation: $284.9K
Chief Financial Officer and Chief Operating Officer
Age: 48
Total Annual Compensation: $367.4K
Chief Development Officer
Age: 53
Total Annual Compensation: $358.7K
Compensation as of Fiscal Year 2016.

Dermira, Inc. Key Developments

Dermira, Inc. Appoints Ian Clements as Vice President, Investor Relations

Dermira, Inc. announced the addition of Ian Clements, Ph.D., to the company's leadership team as vice president, investor relations. Dr. Clements brings over 20 years of industry experience to Dermira. Most recently, he led investor relations and corporate communications at Tobira Therapeutics, Inc., which was acquired by Allergan plc. Previously, he led investor relations and corporate communications at Avanir Pharmaceuticals, Inc., until its acquisition by Otsuka Pharmaceutical Co. Ltd. Dr. Clements also held positions at Sequenom, Inc., the Trout Group LLC, an investor relations agency, and Accelrys, Inc.

Dermira, Inc. Presents at Jefferies 2017 Global Healthcare Conference, Jun-06-2017 11:00 AM

Dermira, Inc. Presents at Jefferies 2017 Global Healthcare Conference, Jun-06-2017 11:00 AM. Venue: Grand Hyatt, 109 E 42nd St, New York, New York, United States. Speakers: Andrew L. Guggenhime, Chief Financial Officer and Chief Operating Officer.

Dermira Mulls Acquisitions

Dermira, Inc. (NasdaqGS:DERM) is seeking acquisitions. Dermira has completed a fixed-income offering in the amount of $250 million. Dermira intends to use the net proceeds that it receives from the note offering for working capital, capital expenditures and other general corporate purposes. Dermira may also use a portion of the net proceeds from the offering to expand its business by in-licensing or acquiring, as the case may be, product candidates, technologies, compounds, other assets, commercial products or complementary businesses; however, Dermira has no current commitments or obligations to do so.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Dermira, Inc., please visit www.dermira.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.